(₹ crores) | Q3FY25 | Q2FY25 | Q3FY24 | QoQ (%) | YoY (%) |
---|---|---|---|---|---|
Total Income | 173.68 | 187.46 | 137.80 | -7.4% | 26.0% |
Total Expenses | 126.97 | 130.28 | 100.99 | -2.5% | 25.7% |
Profit Before Tax | 46.70 | 57.19 | 34.76 | -18.3% | 34.3% |
Tax | 11.41 | 15.06 | 8.76 | -24.2% | 30.3% |
Profit After Tax | 35.30 | 42.13 | 26.00 | -16.2% | 35.8% |
Earnings Per Share | 3.40 | 4.10 | 2.50 | -17.1% | 36.0% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Vijaya Diagnostic Centre Ltd is a prominent player in the healthcare sector, primarily involved in providing diagnostic services. The company operates a network of diagnostic centres that offer a comprehensive range of services, including pathology and radiology tests. Vijaya Diagnostic Centre Ltd is well-regarded for its state-of-the-art facilities and commitment to delivering accurate and timely diagnostic services, which are critical for patient care and treatment plans. As of the latest available information, the company continues to focus on expanding its network and enhancing its service offerings to cater to a growing customer base.
In the third quarter of the fiscal year 2025, Vijaya Diagnostic Centre Ltd reported a total income of ₹173.68 crores. This represents a notable decrease of 7.4% when compared to the preceding quarter (Q2FY25), where the total income was ₹187.46 crores. However, when compared to the third quarter of the previous fiscal year (Q3FY24), the total income grew by 26.0%, reflecting a significant year-over-year increase from ₹137.80 crores. This growth suggests a positive trajectory over the annual period, indicating the company's ability to enhance its revenue base despite a quarterly dip.
The profitability metrics for Vijaya Diagnostic Centre Ltd show a decline in the third quarter of FY25 compared to the previous quarter. The Profit Before Tax (PBT) was ₹46.70 crores, a decrease of 18.3% from ₹57.19 crores in Q2FY25. The Profit After Tax (PAT) also saw a decline, with the figure standing at ₹35.30 crores, down 16.2% from ₹42.13 crores in the previous quarter. However, when compared to the same quarter last year, the company exhibited strong growth, with the PBT increasing by 34.3% from ₹34.76 crores and the PAT rising by 35.8% from ₹26.00 crores. This year-over-year improvement highlights enhanced profitability over the annual period.
The operating expenses for Vijaya Diagnostic Centre Ltd in Q3FY25 were ₹126.97 crores, which is slightly lower than the ₹130.28 crores reported in Q2FY25, marking a quarter-over-quarter decrease of 2.5%. Compared to the same quarter in the previous year, there was a 25.7% increase in operating expenses from ₹100.99 crores. Despite the quarterly reduction in expenses, the year-over-year rise aligns with the increased revenue, indicating investment in operations. The Earnings Per Share (EPS) for Q3FY25 was ₹3.40, which declined by 17.1% from ₹4.10 in the previous quarter but showed a robust annual growth of 36.0% compared to ₹2.50 in Q3FY24.